Yüklüyor......
Protein Kinase Cα Mediates Erlotinib Resistance in Lung Cancer Cells
Overexpression and mutational activation of the epidermal growth factor receptor (EGFR) plays an important role in the pathogenesis of non–small cell lung cancer (NSCLC). EGFR tyrosine-kinase inhibitors (TKIs) are given as a primary therapy for advanced patients with EGFR-activating mutations; howev...
Kaydedildi:
| Yayımlandı: | Mol Pharmacol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
The American Society for Pharmacology and Experimental Therapeutics
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4407729/ https://ncbi.nlm.nih.gov/pubmed/25724832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.115.097725 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|